3Rund D,Krichevsky S,Bar-Cohcn S,et al,Thcrapy-related leukemia:clinical char-actenstics and analysis of new molecular risk factors in 96 adult pmients[J].Leuke-mia,2005.19(11):1919-1928.
4Yokoyama Y.Futagami M.Fukushi Y,et al.Secondary acute nonlymphocyfic leu-kemia following successful chemother apy combining cisplatin,doxorubicm,and cyclophosphamide for stage IV epithelial ovarian cancer[J].Archives of Gynecology and Obstetrics,2000,263(4):206-207.
5Hashibe M,Ritz B,Le AD,et al:Radio therapy for oral cancer as arisk factor for second primary cancers[J].Cancer Lett,2005,220(2):185-195.
6Goh YH, Chon4g VF, Low WK. Temporal bone tumours in patients irradiated for nasopharyngeal neoplasm[J ]. J Laryngol Otol, 1999 ; 113 (3) : 222 - 228.
7Teo PM,Chan AT, Leung SF, et al. Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma-the possibility of radiation carcinogenesis[J]. Eur J cancer, 1999 ;35(2) :219 - 225.
8King AD, Ahuja A J, Teo P, et al. Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma[ J ]. Clin Radiol,2000 ;55(9) :684 - 689.
9Wang CC, Chen ML, Hsu KH, et al. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus [ J ]. Int J Cancer, 2000; 87 (2) :228 - 231.
10Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned IMRT for head-and-neck cancer [J]. Int J Radiat Oncol Biol Phys, 2004, 58(3):663-73.
